Skip to main content
SpringerLink
Log in

Mood Disorders in Transplantation: Bipolar Disorder Spectrum

  • Chapter
  • First Online:
Transplant Psychiatry

Abstract

Bipolar disorder (BD) can pose specific challenges in patients needing and waiting for solid organ transplantation and in organ transplant recipients. Increased disease burden compared to the general population, role of psychotropics in end-stage organ failure, neuropsychiatric adverse effects of standard immunosuppressants, concern for nonadherence, and psychological effects of transplantation are some aspects affecting transplant outcomes in patients with BD. In this chapter, we will review these issues as well as measures to increase the potential for successful transplantation in patients with BD. The complexities of pharmacological management of BD pre- and post-transplantation will also be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. The Lancet Psychiatry. 2022;9(2):137–50.

    Google Scholar 

  2. Judd LL, Schettler PJ, Akiskal HS, Coryell W, Leon AC, Maser JD, et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry. 2008;65(4):386–94.

    Article  Google Scholar 

  3. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543–52.

    Article  Google Scholar 

  4. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–51.

    Article  Google Scholar 

  5. Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M, et al. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord. 2011;133(3):443–9.

    Article  Google Scholar 

  6. Pompili M, Gonda X, Serafini G, Innamorati M, Sher L, Amore M, et al. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 2013;15(5):457–90.

    Article  Google Scholar 

  7. Sylvia LG, Shelton RC, Kemp DE, Bernstein EE, Friedman ES, Brody BD, et al. Medical burden in bipolar disorder: findings from the clinical and health outcomes initiative in comparative effectiveness for bipolar disorder study (bipolar CHOICE). Bipolar Disord. 2015;17(2):212–23.

    Article  CAS  Google Scholar 

  8. Secunda K, Gordon EJ, Sohn MW, Shinkunas LA, Kaldjian LC, Voigt MD, et al. National survey of provider opinions on controversial characteristics of liver transplant candidates. Liver Transpl. 2013;19(4):395–403.

    Article  Google Scholar 

  9. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721–8.

    Article  CAS  Google Scholar 

  10. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the pulmonary transplantation Council of the International Society for heart and lung transplantation. J Heart Lung Transplant. 2015;34(1):1–15.

    Article  Google Scholar 

  11. Faeder S, Moschenross D, Rosenberger E, Dew MA, DiMartini A. Psychiatric aspects of organ transplantation and donation. Curr Opin Psychiatry. 2015;28(5):357–64.

    Article  Google Scholar 

  12. Butler MI, McCartan D, Cooney A, Kelly PO, Ahmed I, Little D, et al. Outcomes of renal transplantation in patients with bipolar affective disorder and schizophrenia: a National Retrospective Cohort Study. Psychosomatics. 2017;58(1):69–76.

    Article  Google Scholar 

  13. Kofman T, Pourcine F, Canoui-Poitrine F, Kamar N, Malvezzi P, François H, et al. Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study. Transpl Int. 2018;31(4):377–85.

    Article  Google Scholar 

  14. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med. 2006;68(5):684–91.

    Article  Google Scholar 

  15. Joe Parks, Patricia Singer, Mary Ellen Foti. National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council 66 Canal Center Plaza, Suite 302, Alexandria VA 22314: 2006 October 2006. Report No.

    Google Scholar 

  16. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–60.

    Article  Google Scholar 

  17. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123–31.

    Article  Google Scholar 

  18. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606–10.

    Article  CAS  Google Scholar 

  19. Abrahamian H, Kautzky-Willer A, Rießland-Seifert A, Fasching P, Ebenbichler C, Kautzky A, et al. Mental disorders and diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):186–95.

    Article  Google Scholar 

  20. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a health management organization database. Bipolar Disord. 2008;10(5):607–16.

    Article  CAS  Google Scholar 

  21. Soreca I, Fagiolini A, Frank E, Houck PR, Thompson WK, Kupfer DJ. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res. 2008;42(11):956–61.

    Article  Google Scholar 

  22. Hayes JF, Marston L, Walters K, King MB, Osborn DPJ. Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014. Br J Psychiatry. 2017;211(3):175–81.

    Article  Google Scholar 

  23. Wilens TE, Biederman J, Adamson JJ, Henin A, Sgambati S, Gignac M, et al. Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study. Drug Alcohol Depend. 2008;95(3):188–98.

    Article  Google Scholar 

  24. Cardinal H, Hébert MJ, Rahme E, Houde I, Baran D, Masse M, et al. Modifiable factors predicting patient survival in elderly kidney transplant recipients. Kidney Int. 2005;68(1):345–51.

    Article  Google Scholar 

  25. de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int. 2006;70(4):757–64.

    Article  Google Scholar 

  26. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int. 2002;62(5):1848–54.

    Article  Google Scholar 

  27. Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish National Cohort Study. JAMA Psychiat. 2013;70(9):931–9.

    Article  Google Scholar 

  28. Post RM, Altshuler L, Leverich GS, Frye MA, Suppes T, McElroy SL, et al. Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder. Compr Psychiatry. 2015;56:21–8.

    Article  Google Scholar 

  29. Keck PE Jr, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull. 1997;33(1):87–91.

    Google Scholar 

  30. Connelly CE, Davenport YB, Nurnberger JI Jr. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry. 1982;39(5):585–8.

    Article  CAS  Google Scholar 

  31. Keck PE Jr, McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, et al. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry. 1996;57(7):292–7.

    CAS  Google Scholar 

  32. Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry. 1996;153(8):993–1000.

    Article  CAS  Google Scholar 

  33. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54(3):216–26.

    Article  Google Scholar 

  34. Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495–553.

    Article  CAS  Google Scholar 

  35. Bowden CL, Gitlin MJ, Keck PE, Perlis RH, Suppes T, Thase ME, JS MI, Charles SC, Altshuler K, Cook I, Cross CD. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1–50.

    Google Scholar 

  36. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161(2):217–22.

    Article  Google Scholar 

  37. Filakovic P, Eric AP. Pharmacotherapy of suicidal behaviour in major depression, schizophrenia and bipolar disorder. Coll Antropol. 2013;37(3):1039–44.

    Google Scholar 

  38. Tondo L, Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. J Clin Psychiatry. 2000;61(Suppl 9):97–104.

    CAS  Google Scholar 

  39. Sheard MH. Lithium in the treatment of aggression. J Nerv Ment Dis. 1975;160(2–1):108–18.

    Article  CAS  Google Scholar 

  40. Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG, et al. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry. 1984;41(7):650–6.

    Article  CAS  Google Scholar 

  41. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. 2001;3. CD003013

    Google Scholar 

  42. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA. 1994;271(12):918–24.

    Article  CAS  Google Scholar 

  43. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006;8(5 Pt 2):625–39.

    Article  CAS  Google Scholar 

  44. Smith KA, Cipriani A. Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord. 2017;19(7):575–86.

    Article  CAS  Google Scholar 

  45. Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord. 1999;1(1):17–24.

    Article  CAS  Google Scholar 

  46. Tondo L, Jamison KR, Baldessarini RJ. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci. 1997;836:339–51.

    Article  CAS  Google Scholar 

  47. Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol. 1994;34(4):280–5.

    Article  CAS  Google Scholar 

  48. James Levenson SF. Clinical manual of psychopharmacology in the medically ill. 2nd ed. APA; 2017.

    Google Scholar 

  49. Grunfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5(5):270–6.

    Article  CAS  Google Scholar 

  50. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10(5):329–45.

    Article  CAS  Google Scholar 

  51. Hestbech J, Hansen HE, Amdisen A, Olsen S. Chronic renal lesions following long-term treatment with lithium. Kidney Int. 1977;12(3):205–13.

    Article  CAS  Google Scholar 

  52. Rej S, Elie D, Mucsi I, Looper KJ, Segal M. Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders. Drugs Aging. 2015;32(1):31–42.

    Article  CAS  Google Scholar 

  53. Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015;386(9992):461–8.

    Article  CAS  Google Scholar 

  54. Bendz H, Schon S, Attman PO, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77(3):219–24.

    Article  CAS  Google Scholar 

  55. Roxanas M, Grace BS, George CR. Renal replacement therapy associated with lithium nephrotoxicity in Australia. Med J Aust. 2014;200(4):226–8.

    Article  Google Scholar 

  56. Bendz H, Aurell M, Lanke J. A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed. Eur Psychiatry. 2001;16(4):199–206.

    Article  CAS  Google Scholar 

  57. Aiff H, Attman PO, Aurell M, Bendz H, Schon S, Svedlund J. End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014;24(4):540–4.

    Article  CAS  Google Scholar 

  58. Bocchetta A, Ardau R, Carta P, Ligas F, Sardu C, Pani A, et al. Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med. 2013;11:33.

    Article  CAS  Google Scholar 

  59. Aiff H, Attman PO, Aurell M, Bendz H, Schon S, Svedlund J. The impact of modern treatment principles may have eliminated lithium-induced renal failure. J Psychopharmacol. 2014;28(2):151–4.

    Article  Google Scholar 

  60. Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP. Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study. PLoS Med. 2016;13(8):e1002058.

    Article  Google Scholar 

  61. Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schon S, et al. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol. 2015;29(5):608–14.

    Article  CAS  Google Scholar 

  62. Werneke U, Ott M, Renberg ES, Taylor D, Stegmayr B. A decision analysis of long-term lithium treatment and the risk of renal failure. Acta Psychiatr Scand. 2012;126(3):186–97.

    Article  CAS  Google Scholar 

  63. Tondo L, Abramowicz M, Alda M, Bauer M, Bocchetta A, Bolzani L, et al. Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord. 2017;5(1):27.

    Article  Google Scholar 

  64. Kahl KG, Eckermann G, Frieling H, Hillemacher T. Psychopharmacology in transplantation medicine. Prog Neuro-Psychopharmacol Biol Psychiatry. 2019;88:74–85.

    Article  CAS  Google Scholar 

  65. Heffernan SP, Breitbart WS, Lederberg MS. Pscycho-oncology In: Kaplan & Sadock’s comprehensive textbook of psychiatry 10th ed. Philadelphia: LWW; 2017.

    Google Scholar 

  66. Butler M, McCartan D, Cooney A, O'Kelly P, Ahmed I, Little D, et al. Outcomes of renal transplantation in patients with bipolar affective disorder and schizophrenia: a National Retrospective Cohort Study. Psychosomatics. 2016;58

    Google Scholar 

  67. Pang M, Mousa O, Chen W-C, Pungpapong S, Vasquez A, Harnois D. Perioperative factors influencing readmissions of liver transplant recipients with bipolar disorder: 893. Am J Gasteroenterol. 2016:111.

    Google Scholar 

  68. H. G. Management of bipolar disorder in liver transplantation: a single Center experience international J Transplant Res Med 2015;1(3).

    Google Scholar 

  69. Molnar MZ, Eason JD, Gaipov A, Talwar M, Potukuchi PK, Joglekar K, et al. History of psychosis and mania, and outcomes after kidney transplantation–a retrospective study. Transpl Int. 2018;31(5):554–65.

    Article  CAS  Google Scholar 

  70. Judd LL, Schettler PJ, Brown ES, Wolkowitz OM, Sternberg EM, Bender BG, et al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatr. 2014;171(10):1045–51.

    Article  Google Scholar 

  71. Ithman M, Malhotra K, Bordoloi M, Singh G. Treatment-refractory mania with psychosis in a Post-transplant patient on tacrolimus: a case report. Clin Med Res. 2018;16(1–2):47–9.

    Article  Google Scholar 

  72. Bhangle SD, Kramer N, Rosenstein ED. Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int. 2013;33(8):1923–32.

    Article  CAS  Google Scholar 

  73. Dave V, Mulley W, Kanellis J, Summers S. Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection. Nephrology (Carlton). 2015;20(Suppl 1):2–5.

    Article  Google Scholar 

  74. Aramada H, Kipp G, Rancurella M, Oleniacz S, Zahid S, Sureshkumar K, Chopra B. Resolution of Calcineurin inhibitor induced psychosis in a kidney transplant recipient by switching to Belatacept. Am J Kidney Dis. 2019;73(5):653.

    Article  Google Scholar 

  75. Huyse FJ, Touw DJ, van Schijndel RS, de Lange JJ, Slaets JP. Psychotropic drugs and the perioperative period: a proposal for a guideline in elective surgery. Psychosomatics. 2006;47(1):8–22.

    Article  CAS  Google Scholar 

  76. Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, et al. Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disord. 2019;7(1):16.

    Article  Google Scholar 

  77. Beasley AK, Larson CC, Garcia-Pittman EC. Lithium rechallenge after renal transplant. Ment Health Clin. 2017;7(2):46–50.

    Article  Google Scholar 

  78. Rodelo-Haad C, Aguera ML, Ortega R, Martinez-Lopez A, Navarro MD, Rodriguez-Benot A, et al. Lithium-associated nephropathy in the renal allograft. Kidney Int. 2018;93(1):273.

    Article  Google Scholar 

  79. Moss MC, Kozlowski T, Dupuis R, Detwiler R, Lee RM, Deyo JC. Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? Transplantation. 2014;97(3):e23–4.

    Article  Google Scholar 

  80. Dube GCR, Tsapeppas D, Khorassani F, Wiener I. Excellent outcomes of kidney transplant in patients with bipolar disorder [abstract]. Am J Transplant. 2013:13.

    Google Scholar 

  81. Fireman M, DiMartini A, Crone C. Organ transplantation. In: Levenson JL, Ferrando SJ, editors. Clinical manual of psychopharmacology in medically ill. 2nd ed. Arlington, VA: APA; 2017. p. 597–622.

    Google Scholar 

  82. Gamboa MC, Ferrando SJ. Psychopharmacology in transplant patients. In: Sher Y, Maldonado JR, editors. Psychosocial care of end-stage organ disease and transplant patients. Cham: Springer; 2019. p. 453–70.

    Chapter  Google Scholar 

  83. Miklowitz DJ, Efthimiou O, Furukawa TA, Scott J, McLaren R, Geddes JR, et al. Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis. JAMA Psychiat. 2021;78(2):141–50.

    Article  Google Scholar 

  84. Jonathan GK, Dopke CA, Michaels T, Bank A, Martin CR, Adhikari K, et al. A smartphone-based self-management intervention for bipolar disorder (LiveWell): user-Centered development approach. JMIR Ment Health. 2021;8(4):e20424.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

    Rabin Dahal

  2. Department of Psychiatry and Surgery (Transplant), Yale University School of Medicine, New Haven, CT, USA

    Paula C. Zimbrean

Authors
  1. Rabin Dahal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paula C. Zimbrean
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rabin Dahal .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

    Paula C. Zimbrean

  2. Department of Psychiatry, Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

  3. Department of Behavioral Health, Inova Fairfax Hospital, George Washington University, Falls Church, VA, USA

    Catherine Crone

  4. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

    Andrea F. DiMartini

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dahal, R., Zimbrean, P.C. (2022). Mood Disorders in Transplantation: Bipolar Disorder Spectrum. In: Zimbrean, P.C., Sher, Y., Crone, C., DiMartini, A.F. (eds) Transplant Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-15052-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15052-4_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15051-7

  • Online ISBN: 978-3-031-15052-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation